Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/30/22
End: 03/04/23
Due: 03/04/24
Phase: N/A
Priority: Normal
Start: 11/07/22
End: 04/01/29
Due: 04/01/30
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Dose-ranging, PK, Safety, Efficacy Study of Osanetant in Patients With Moderate/Severe VMS Associated With Menopause | NCT05325775 | Acer Therapeutics Inc. | user2@example.com | None | 2022-03-30 | 2023-03-04 | 2024-03-04 | - | - | 2025-07-14 |
| Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome | NCT05432466 | Acer Therapeutics Inc. | user2@example.com | None | 2022-11-07 | 2029-04-01 | 2030-04-01 | - | - | 2025-07-14 |